Companies / 4D Molecular Therapeutics, Inc. / Activity
Activity — 4D Molecular Therapeutics, Inc.
12 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Mar 20, 2026 | Gupta Ashoo Executive | Sell | Common Stock | $689 | -80 -0.17% | 47,055 0.07% of shares | low |
| Mar 20, 2026 | Gupta Ashoo Executive | Sell | Common Stock | $2.7K | -310 -0.66% | 46,914 0.07% of shares | low |
| Jun 17, 2026 | Sblendorio Glenn Director | Grant | Stock Option (Right to Buy) | — | +50K | 50,000 0.07% of shares | low |
| Jun 17, 2026 | Milligan John F Director | Grant | Stock Option (Right to Buy) | — | +75K | 75,000 0.11% of shares | low |
| Mar 25, 2026 | Bizily Scott Executive | Grant | Stock Option (Right to Buy) | — | +217K | 217,000 0.31% of shares | low |
| Mar 25, 2026 | Simms Christopher Paul Executive | Grant | Stock Option (Right to Buy) | — | +219K | 219,000 0.32% of shares | low |
| Mar 25, 2026 | Kirn David CEO | Grant | Stock Option (Right to Buy) | — | +750K | 750,000 1.08% of shares | low |
| Mar 20, 2026 | Gupta Ashoo Executive | Exercise | Restricted Stock Units | — | -221 -6.68% | 3,087 <0.01% of shares | low |
| Mar 20, 2026 | Gupta Ashoo Executive | Exercise | Restricted Stock Units | — | -865 -6.66% | 12,119 0.02% of shares | low |
| Mar 20, 2026 | Gupta Ashoo Executive | Exercise | Common Stock | — | +221 +0.47% | 47,135 0.07% of shares | low |
| Mar 20, 2026 | Gupta Ashoo Executive | Exercise | Common Stock | — | +865 +1.87% | 47,224 0.07% of shares | low |
| Jan 5, 2026 | Sblendorio Glenn Director | Grant | Stock Option (Right to Buy) | — | +45K | 45,000 0.07% of shares | low |